Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing

Completed

Conditions studied: Pregnancy Following IVF With PGS/PGD

In brief

The purpose of this study is to collect blood samples from pregnant women who achieved pregnancy following in-vitro fertilization (IVF) with Natera's preimplantation aneuploidy screening (with or without single gene gene testing). These samples will be used for test development of non-invasive prenatal diagnostic testing.

Key facts

Study ID

NCT01546324

Run by

Natera, Inc.

People needed

16

Starts

2012-02-01

Expected to finish

2013-08-01

Last updated by the study team

2013-08-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Pregnant women willing to donate a blood sample during the first or second trimester of their pregnancy (approximately 8-17 weeks gestation)
• Use of Natera (formerly Gene Security Network)'s commercial preimplantation genetic testing (PGS/PGD)to achieve the current pregnancy

You may not qualify if…

• Pregnant women who did not use Natera (formerly Gene Security Network)'s PGS/PGD testing to achieve their current pregnancy

Where it is running

• Natera, Inc — Redwood City, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.